Earlier this week, leaders of associations representing the Council of State Bioscience Association’s New England region (Region 7) met to discuss their expectations for 2013. The meeting was attended by Region 7 Chairman Nathan Tinker (New York), Bob Coughlin (Massachusetts), Paul Pescatello (Connecticut), Claire Deselle (Maine) and Ritchard Engelhardt (BayBio). The group discussed federal priorities facing the industry, as well as opportunities and challenges in each New England state. The executives also explored opportunities to expand on their regional collaboration to raise the profile of the industry as a whole.
The Council of State Bioscience Associations (CSBA) is a confederation of state-based, non-profit trade organizations each governed by its own board of directors. The common mission of the members of the CSBA is to promote public understanding and to advocate for public policies that support the responsible development of the bioscience industry. These groups are recognized by BIO as affiliate organizations in their respective states.
BIO has committed to provide additional support to BAM for local advocacy projects and to provide continued access to state-focused industry information collected by the national organization.
Stephen J. Ubl, president and CEO of AdvaMed, the Advanced Medical Technology Association, has released the following statement about the recent fiscal cliff legislation:
“The effort to repeal the medical device tax will continue. The passage of a scaled-back fiscal cliff package that did not address the medical device tax does not diminish the need to repeal the tax. It also does not diminish the bipartisan support for the repeal effort, which is premised on the recognition that the tax is costing jobs and threatening patient care. We urge Congress to repeal the device tax as it returns to address the other pressing tax and budget issues facing the country, so that we can avoid going over the medical technology innovation cliff.
“We appreciate the efforts of Members on both sides of the aisle and on both sides of Capitol Hill, and we will continue to work with them to get Congress to act as soon as possible.
“AdvaMed also is disappointed in the cuts to imaging and diabetes-related services that are a part of the package passed by Congress. We believe these cuts will hurt access to important technologies that Medicare beneficiaries depend upon.”
The Bioscience Association of Maine is aligned with AdvaMed on this endeavor. Stay tuned here for updates via blog or check us out on Twitter @MaineBioscience.
As you may have heard, there were gains and losses in the recent passage of fiscal cliff legislation. Biofuels Digest broke it down for us as follows:
Cellulosic biofuels producer tax credit. Under current law, facilities producing cellulosic biofuel can claim a $1.01 per gallon production tax credit on fuel produced before the end of 2012. This provision was created in the 2008 Farm Bill. The provision would extend this production tax credit for one additional year, for cellulosic biofuel produced through 2013.
The cellulosic biofuel producer credit is redesignated “second generation biofuel producer credit” and is (i) expanded to apply to liquid fuel derived from cultivated algae, cyanobacteria, or lemna and (ii) extended to apply to qualified fuel production before January 1, 2014. This provision is estimated to cost $59 million over ten years.
Incentives for biodiesel and renewable diesel. The bill extends for two years, through 2013, the $1.00 per gallon tax credit for biodiesel, as well as the small agri-biodiesel producer credit of 10 cents per gallon. The bill also extends through 2013 the $1.00 per gallon tax credit for diesel fuel created from biomass. This provision is estimated to cost $2.181 billion over ten years.
The biodiesel tax incentive expired on Dec. 31, 2011. A recent study found that the industry would have produced an additional 300 million gallons this year with the tax incentive in place. That would have supported some 19,213 additional jobs, for a total of 83,258 jobs supported by the industry nationwide, according to the study, conducted by Cardno ENTRIX, an international economics consulting firm.
Cellulosic biofuels bonus depreciation. Under current law, facilities producing cellulosic biofuel can expense 50 percent of their eligible capital costs in the first year for facilities placed-in-service by the end of 2012. This provision was created in the 2008 Farm Bill. The provision would extend this bonus depreciation for one additional year for facilities placed-in-service before the end of 2013 – and is also extended to algae producers.
The proposal also expands the definition of qualified cellulosic biofuel production to include algae-based fuel. This provision is estimated to cost less than $500,000 over ten years.
What’s out – mandatory funding for Farm Bill energy programs
Agricultural Programs. Section 701 of the Bill extended all provisions of the 2008 Farm Bill through September 30, 2012 – including funding levels for mandatory programs. But, in a last-minute surprise, the Act excludes funding for energy title programs from the extension of the already expired Farm Bill.
Legislation passed by the U.S. Senate earlier this year to extend the Farm Bill for five years set mandatory funding levels each year for renewable energy and energy efficiency programs. A five-year Farm Bill passed by the House Agriculture Committee earlier this year provided discretionary funding for these programs. And draft legislation for a one-year extension of the current Farm Bill agreed to by the House and Senate Agriculture Committee leaders and released last week set mandatory funding levels for these programs in 2013.
Programs affected include Rural Energy for America Program (REAP), Biomass Crop Assistance Program (BCAP), Biorefinery Assistance Program (BAP) and Biobased Markets Program (Biopreferred).
For the complete guide to biofuels legislation, visit: http://www.biofuelsdigest.com/bdigest/2013/01/03/the-fiscal-cliff-deal-the-definitive-biofuels-guide/
It gives us great pleasure to announce the official launch of BAM’s new website. Several months ago we joined forces with iBec Creative, together we worked towards one goal; to develop and create a new, contemporary, user-friendly website for our members and potential members that would rival the sites of other bioscience organizations in New England and beyond.
Along with a new look and feel, the website also offers several features; some new, some familiar, but improved:
- Cost Saving Programs
- Job Board
- Blog at www.mainebioscience.org/blog
- Join BAM/renew membership with ease
- Event Signup and Registration
- Education & Training
- Doing Business In Maine
- ME Bioscience Collaborative
- Member Company Profiles
Please take a few minutes to explore the website, www.mainebioscience.org. We encourage our members to send us information that they would like posted on the Job Board, in our News and Advocacy section and etc. If you would like your company’s information updated please email Lea, firstname.lastname@example.org and she will be happy to make those changes. Thank you.
Once again we have the great fortune of having the annual internationally attended BIO Conference in our own backyard. This year’s conference, from June 18th-21st, will be held at the Boston Convention & Exhibition Center.
We invite you to present your company and its promotional materials alongside your peers at this high profile event.
Our pavilion (equivalent to 4 booths with a semi-private meeting area) is situated in prime territory – just as you walk into the Exhibition Hall! This should ensure considerable foot traffic and visibility.
The fee schedule for participation is as follows:
For member companies with 1-50 employees: $500
member companies with >50 employees: $1,000
non-member companies with 1-50 employees: $650 (complimentary membership to BAM included)
non-member companies with >50 employees: $1,350 (complimentary membership to BAM included)
The price of sponsorships and additional display considerations can be obtained upon request.
We can only accommodate a limited number of companies and already several have secured space. Two exhibitor passes will be available for the companies that are displaying. However, if you are not personally able to represent your company at the booth, a representative of BAM will gladly work with you to direct visitors to your materials.
Your next step is to contact Lea Tranchemontagne at 207-571-9365 or email@example.com to let us know that you will be joining us in Boston.
As a member of the Bioscience Association of Maine (BAM), I want to make you aware of new benefits that can help your company save on the cost of goods and services. BAM, in partnership with the Biotechnology Industry Organization (BIO), the international trade association, offers BAM members discounts and other benefits from leading service providers. There is no cost to participate in any of these cost-savings programs; they are a benefit of your membership to BAM.
The new cost-savings programs include:
Shipping services from FedEx
Used lab equipment from BioSurplus
Gases (packaged, min-bulk and bulk) from Linde’s Maine affiliate
News distribution services from Business Wire
Government financial incentives and tax credits from Bedford International
Industry publications and databases from Elsevier Business Intelligence
These represent just a few of the many cost-savings available to BAM members. For more information about these programs, contact Lea at the BAM office.
The Bioscience Association of Maine is enhancing communications with our membership and to the community at large as part of a larger effort to continually increase the value provided by our organization. The focus of the blog will be to alert you to opportunities, issues and events that impact our bioscience industry in the state and nationally.
If you have any specific topics you would like to see addressed here or other comments, please contact Lea Tranchemontagne at firstname.lastname@example.org.